Skip to main content
. 2020 Apr 19;21(8):2851. doi: 10.3390/ijms21082851

Table 1.

Composition of Akt isoforms in cells of various origins.

Cell Type Origin Disease Cat. No. Akt1 (%) Akt2 (%) Akt3 (%)
SH-SY5Y Bone marrow Neuroblastoma CRL-2266, ATCC 40 ± 3 10 ± 1 50 ± 5
HepG2 Liver Hepatocellular carcinoma HB-8065, ATCC 86 ± 4 14 ± 5 0 ± 0
HMC3 Brain, microglia Neuroinflammation CRL-3304, ATCC 75 ± 7 12 ± 1 13 ± 1
Jurkat Peripheral blood Acute T-cell leukemia TIB-152, ATCC 55 ± 6 45 ± 2 0 ± 0
Caco-2 Colon Colorectal adenocarcinoma HTB-37, ATCC 46 ± 4 54 ± 5 0 ± 0
A549 Lung Lung carcinoma CCL-185, ATCC 28 ± 2 57 ± 5 15 ± 1
HEK293 Kidney Normal embryonic kidney CRL-1573, ATCC 37 ± 3 24 ± 2 39 ± 3
MDA-MB-231 Breast Mammary adenocarcinoma CRM-HTB-26, ATCC 71 ± 6 11 ± 1 18 ± 2
Pre-adipocytes Subcutaneous adipose tissue Obesity SP-2006-3, Zen-Bio 57 ± 5 23 ± 2 19 ± 2
Adipocytes Subcutaneous adipose tissue Obesity SA-1006-3, Zen-Bio 58 ± 5 35 ± 3 7 ± 1